Factor VIII-Related Activities in Normal, Haemophilic and von Willebrand’s Disease Platelet Fractions

1978 ◽  
Vol 40 (02) ◽  
pp. 288-301 ◽  
Author(s):  
P Meucci ◽  
I R Peake ◽  
A L Bloom

SummaryFactor VIII-related activities have been studied in platelet fractions in order to try to reconcile the conflicting findings of other workers, and to extend the studies. In platelets from 16 normal subjects procoagulant factor VIII was not detected. The amount of factor VIII-related antigen (FVIIIR: AG) in the cytosol per mg of protein was about twice that in the membrane fraction and about ten times that in the debris fraction. There was no significant difference between the amount of FVIIIR: AG and ristocetin cofactor (RistCof) activity in each fraction. The findings in haemophilic platelets were similar. In von Willebrand’s disease (vWd) one serverely affected patient had no detectable factor VIII related activities in any platelet fraction. In 5 patients with intermediate vWd results were normal. In a further 5, with more prolonged bleeding times, no FVIIIR: RistCof was detected in platelets, despite a normal amount of FVIIIR: AG in the cytosol and debris. The electrophoretic mobility of cytosol FVIIIR: AG was increased in all normals and patients, while that in the membrane and debris fractions had normal mobility. Cytosol FVIIIR: AG eluted later than normal FVIIIR: AG on gel filtration on Sepharose 2B, and also showed reduced antibody binding in an immunoradiometric assay. Precipitation of FVIIIR: AG by concanavalin A was incomplete in all platelet fractions from normals, and even more reduced in vWd platelet fractions. The results suggest the possibility of two types of platelet FVIIIR: AG.A factor VIII-related antigen was shown to be associated with normal washed platelets by immunofluorescence techniques (Bloom et al. 1973). Since then, several studies have been reported on the localisation of factor VIII related antigen (FVIIIR: AG), factor VIII procoagulant activity (FVIII: C) and factor VIII related ristocetin cofactor activity (FVIIIR: RistCof) within the platelets. Initially, Howard et al. (1974) indicated that FVIIIR: AG was firmly bound to the platelet membrane, and noted that in lysed platelets the level of FVIIIR: AG as measured by electroimmunodiffusion was higher than that in whole platelet suspensions. However, further studies by Nachman and Jaffe (1975) showed that FVIIIR: AG was also present to a considerable extent in the granules, and they detected none in the platelet cytosol. Bouma and colleagues (1975) were, however, able to find FVIIIR: AG and FVIIIR: RistCof in the cytosol upon freezing and thawing platelets. This FVIIIR: AG had an electrophoretic mobility comparable to that of normal plasma. They also noted that platelets which were air dried apparently had a granular FVIIIR:AG localisation by immunfluorescence; however, intact platelets in suspension did not stain by this method.Recently Ruggeri et al. (1977) and Sultan et al. (1977) have also found FVIIIR: AG in the cytosol, and the former authors reported it to have increased electrophoretic mobility when compared to normal plasma FVIIIR:AG. Results concerning the localisation of FVIIIR: AG in normal platelets have thus been conflicting. Similarly, in the few reports available concerning platelet FVIIIR: AG in von Willibrand’s disease variable results have also been obtained (Ruggeri et al. 1977, Howard et al. 1974, Shearn et al. 1974 and Bouma et al. 1975).In this study we report on the localisation of factor VIII-related activities in normal, haemophilic and von Willebrand’s disease platelets using available standard techniques as well as precipitation of FVIIIR: AG with the plant lectin concanavalin A, a procedure which has been shown to detect abnormal forms of FVIIIR:AG in certain types of von Willebrand’s disease (Peake and Bloom 1977).

1977 ◽  
Author(s):  
D. Böttcher ◽  
K. Hasler ◽  
A.H. Sutor

An abnormal electrophoretic mobility of factor VIII related antigen(VIIIRAg) is a well known finding in patients with variants of von Willebrand’s disease (vWd), but it has also been described in patients with typical vWd. We have studied 12 patients with vWd and 5 members of a family with a variant of the disease, characterized by normal factor VIII activity and normal VIIIRAg but low or absent ristocetin cofactor activity. The electrophoretic mobility of VIIIRAg as measured by two dimensional immunelectrophoresis at pH 8.6 was grossly abnormal in all patients with a variant of vWd corresponding to the bleeding tendency. This correlation between clinical symptoms and abnormal electrophoretic mobility of VIIIRAg was not found in those patients with vWd, in whom the mobility of VIIIRAg was also grossly abnormal. Chromatography of cryoprecipitate from patients with the described variant of vWd revealed a delayed elution of VIIIRAg with a characteristic pattern, whereas the patients with typical vWd but abnormal electrophoretic mobility of VIIIRAg had normal elution patterns. It is suggested that an abnormal electrophoretic mobility of VIIIRAg is a common finding also in patients with typical vWd.


1975 ◽  
Author(s):  
B. N. Bouma ◽  
J. M. Hordijk-Hos ◽  
S. de Graaf ◽  
J. A. van Mourik ◽  
J. J. Sixma

The presence of Factor VIII-related antigen (F VIIIRA) in haemostatic plugs was demonstrated by immunofluorescent techniques. Immunofluorescent studies of intact washed platelets incubated with rabbit antifactor VIII in suspension showed that most of the platelets did not stain, whereas a positive staining was obtained after disruption of the membranes after air-drying of a drop of the same platelet suspension on a glass slide. This suggested that F VIIIRA was localized inside the platelets. F VIIIRA was detected in the supernatant of washed platelet suspensions that had been lysed by freezing and thawing (4 ×). This platelet F VIIIRA could not be distinguished from plasma factor VIII in immuno diffusion studies and cross-immuno-electrophoresis using antinormal factor VIII and the antisera against the low ionic strength subunits of factor VIII. The concentration of F VIIIRA in normal platelets was about 60 times as high as the concentration in plasma. Normal concentrations of F VIIIRA were detected in blood platelets and in 13 out of 15 patients with Von Willebrand’s Disease. No F VIIIRA was detected in the plasma of these patients with Von Willebrand’s Disease. Blood platelet F VIIIRA of normal platelets and of platelets of patients with Von Willebrand’s Disease supported the Ristocetin aggregation of washed platelets.


1977 ◽  
Author(s):  
Y. Sultan ◽  
J. Lamazière ◽  
P. Maisonneuve

We have previously shown that patients with severe Von Willebrand’s disease (VWd), mainly homozygotes had no factor VIII related antigen (F VIIIRA) in their platelets as well as no Von Willebrand activity (F VIIIVW) as measured by the ristocetin cofactor assay. In all other patients with less severe form of the disease platelet F VIIIRA was detectable. In normal controls electrophoretic mobility of platelet F VIIIRA was found to be identical to the mobility of plasma VIII-RA either on the total platelet lysate or after isolation on sepharose 4B columns.In the present study F VIIIVW and the electrophoretic mobility of F VIIIRA were compared in platelet extracts and the plasma of a number of patients. Seven of the ten patients tested were genetic variants of vwd with very low ratio of F VIIIVW/F VIIIRA suggesting a non functional protein with an increased electrophoretic mobility : one group of patients showed abnormalities of plateletF VIIIRA identical to those found in the plasma. However another group showed a high ratio of F VIIIVW/F VIIIRA suggesting a more active protein than the one in patient’s plasma although the platelet F VIIIRA had an increased electrophoretic mobility. These results are the first example of a F VIIIRA with abnormal electrophoretic mobility associated to high F VIIIVW activity. The loss of F VIIIVW in the patient’s plasma would be a secondary process occuring after F VIIIRA is released in the circulation.


1979 ◽  
Vol 42 (03) ◽  
pp. 848-854 ◽  
Author(s):  
Paul M Ness ◽  
Herbert A Perkins

SummaryAn enzyme immunoassay (EIA) system has been developed to measure factor VIII- related antigen (VIIIAGN). This assay gives similar results to the commonly used Laurell electroimmunodiffusion (EID) assay for VIIIAGN as shown by comparison of both techniques with samples from healthy controls, patients with hemophilia A, and patients with von Willebrand’s disease. The assay also has a greater precision than the EID technique as demonstrated by multiple assays of aliquots of a single sample. The use of this EIA test for VIIIAGN is simple and employs inexpensive reagents and equipment. The use of expensive antisera is minimized. EIA for VIIIAGN has the advantage of increased sensitivity compared to Laurell EIA.


Blood ◽  
1986 ◽  
Vol 67 (2) ◽  
pp. 465-468 ◽  
Author(s):  
HR Gralnick ◽  
SB Williams ◽  
LP McKeown ◽  
ME Rick ◽  
P Maisonneuve ◽  
...  

Abstract 1-D-Amino(8-D-arginine)-vasopressin (DDAVP) infusion in three patients with type IIa von Willebrand's disease (vWD) resulted in a normalization of the factor VIII coagulant, factor VIII-related antigen, and von Willebrand factor (vWF) (ristocetin cofactor) activities and the bleeding time. The normalization of these hemostatic parameters persisted for four hours. Over the same time period there was a marked increase in the quantity of the vWF multimers when blood was collected in the presence of protease inhibitors. The vWF multimers present were even larger than the normal. When blood was collected in the absence of protease inhibitors, a smaller increase in the plasma vWF multimers was observed and fewer of the intermediate and larger vWF multimers were seen; multimers larger than those present in normal plasma were not visualized. The platelet vWF multimers and activities did not change with or without inhibitors. These studies suggest that there is a subgroup of patients with type IIa vWD who respond to DDAVP with complete normalization of their hemostatic abnormalities and whose vWF is sensitive to proteolysis.


Blood ◽  
1981 ◽  
Vol 58 (5) ◽  
pp. 873-879 ◽  
Author(s):  
W Hanna ◽  
D McCarroll ◽  
T McDonald ◽  
P Painter ◽  
J Tuller ◽  
...  

Abstract The clinical course and coagulation profile of a pregnant patient with variant von Willebrand's disease were followed from the second trimester through puerperium. The clinical course was characterized by a normal delivery and absence of abnormal bleeding or need for replacement therapy. The coagulation profile demonstrated an increase in factor VIII procoagulant activity, factor-VIII-related antigen, and platelet aggregation activity in response to ristocetin prior to delivery. Postpartum, these factors decreased to prepregnancy values with distinctly different patterns. Factor VIII procoagulant activity continued to rise for 5 days after delivery and then decreased with a half-life of approximately 6 days. Factor-VIII-related antigen began to decrease just prior to delivery, displaying a half-life or approximately 6 days. Ristocetin cofactor activity, however, dropped immediately postpartum and displayed a half-life of approximately 6 hr. The ristocetin cofactor activity was associated with factor-VIII- related antigen, which displayed a significantly smaller molecular weight than does normal factor-VIII-related antigen. Larger aggregates of factor-VIII-related antigen. Larger aggregates of factor-VIII- related antigen did not appear during the pregnancy, and ristocetin cofactor activity could not be demonstrated in fragments of less than 0,8 x 10(6).


Sign in / Sign up

Export Citation Format

Share Document